Cancer treatments often have a narrow therapeutic index, meaning the difference between an effective dose and a toxic dose is small. Adverse effects such as neutropenia, hepatotoxicity, and gastrointestinal problems can necessitate dose modification to ensure patient safety and improve their quality of life.
